Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Motion for debate: osteoarthritis clinical trials have not identified efficacious therapies because traditional imaging outcome measures are inadequate.

Guermazi A, Roemer FW, Felson DT, Brandt KD.

Arthritis Rheum. 2013 Nov;65(11):2748-58. doi: 10.1002/art.38086. No abstract available.

2.

Plain radiography as an outcome measure in clinical trials involving patients with knee osteoarthritis.

Mazzuca SA, Brandt KD.

Rheum Dis Clin North Am. 1999 May;25(2):467-80, ix. Review.

PMID:
10356429
3.

Compositional Magnetic Resonance Imaging Measures of Cartilage--Endpoints for Clinical Trials of Disease-modifying Osteoarthritis Drugs?

Guermazi A, Crema MD, Roemer FW.

J Rheumatol. 2016 Jan;43(1):7-11. doi: 10.3899/jrheum.150663. Review. No abstract available.

PMID:
26724316
4.

Which is the best radiographic protocol for a clinical trial of a structure modifying drug in patients with knee osteoarthritis?

Brandt KD, Mazzuca SA, Conrozier T, Dacre JE, Peterfy CG, Provvedini D, Ravaud P, Taccoen A, Vignon E.

J Rheumatol. 2002 Jun;29(6):1308-20. Review. No abstract available.

PMID:
12064851
5.

Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs.

Brandt KD, Mazzuca SA.

Arthritis Rheum. 2005 Nov;52(11):3349-59. Review. No abstract available.

6.

Imaging techniques in osteoarthritis.

Hunter DJ, Guermazi A.

PM R. 2012 May;4(5 Suppl):S68-74. doi: 10.1016/j.pmrj.2012.02.004. Review.

PMID:
22632705
7.

The randomized clinical trial of doxycycline in knee osteoarthritis: comment on the editorial by Dieppe.

Brandt KD, Mazzuca SA.

Arthritis Rheum. 2006 Feb;54(2):684. No abstract available.

8.

Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis.

Altman RD, Abadie E, Avouac B, Bouvenot G, Branco J, Bruyere O, Calvo G, Devogelaer JP, Dreiser RL, Herrero-Beaumont G, Kahan A, Kreutz G, Laslop A, Lemmel EM, Menkes CJ, Pavelka K, Van De Putte L, Vanhaelst L, Reginster JY; Group for Respect of Excellence and Ethics in Science (GREES)..

Osteoarthritis Cartilage. 2005 Jan;13(1):13-9. Review.

9.

Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI.

Raynauld JP, Martel-Pelletier J, Bias P, Laufer S, Haraoui B, Choquette D, Beaulieu AD, Abram F, Dorais M, Vignon E, Pelletier JP; Canadian Licofelone Study Group..

Ann Rheum Dis. 2009 Jun;68(6):938-47. doi: 10.1136/ard.2008.088732. Epub 2008 Jul 23.

PMID:
18653484
10.

Efficacy of intraarticular hyaluronan in the treatment of knee osteoarthritis: comment on the article by Brandt et al.

Moskowitz RW, Altman RD.

Arthritis Rheum. 2001 Jun;44(6):1471-6. No abstract available.

11.

Advanced imaging in osteoarthritis.

Hunter DJ.

Bull NYU Hosp Jt Dis. 2008;66(3):251-60. Review.

12.
13.

Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade.

Grunke M, Schulze-Koops H.

Ann Rheum Dis. 2006 Apr;65(4):555-6. No abstract available.

14.

Advances in radiographic imaging of progression of hip and knee osteoarthritis.

Vignon E, Conrozier T, Hellio Le Graverand MP.

J Rheumatol. 2005 Jun;32(6):1143-5. Review. No abstract available.

PMID:
15977349
15.

Development of a Disease-Modifying OA Drug (DMOAD) in Knee Osteoarthritis: The Example of Sprifermin.

Marhardt K, Muurahainen N.

Drug Res (Stuttg). 2015 Nov;65 Suppl 1:S13. doi: 10.1055/s-0035-1558063. Epub 2015 Nov 4. No abstract available.

16.

Assessment and follow-up of osteoarthritis of the limbs--outcome measures.

Lequesne M.

Schweiz Med Wochenschr Suppl. 1996;80:8S-9S. No abstract available.

PMID:
8795115
17.
18.

Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: Data from the OAI progression cohort.

Roubille C, Martel-Pelletier J, Abram F, Dorais M, Delorme P, Raynauld JP, Pelletier JP.

Semin Arthritis Rheum. 2015 Dec;45(3):257-67. doi: 10.1016/j.semarthrit.2015.05.001. Epub 2015 May 15.

PMID:
26094904
19.

Pharmacological therapy of osteoarthritis.

Hochberg MC, Dougados M.

Best Pract Res Clin Rheumatol. 2001 Oct;15(4):583-93. Review.

PMID:
11567541
20.

A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon) as a structure modifying therapy in osteoarthritis of the hip and knee.

Pavelká K, Gatterová J, Gollerova V, Urbanová Z, Sedlácková M, Altman RD.

Osteoarthritis Cartilage. 2000 Sep;8(5):335-42.

Supplemental Content

Support Center